Holter monitoring and long-term prognosis in hypertrophic cardiomyopathy

Cardiology (Switzerland)

Volumn 122, Issue 1, 2012, Pages 44-54

  Kawasaki, Tatsuya ^a   Sakai, Chieko ^a   Harimoto, Kuniyasu ^a   Yamano, Michiyo ^a   Miki, Shigeyuki ^a   Kamitani, Tadaaki ^a   Sugihara, Hiroki ^a  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Heart rate; Holter monitoring; Hypertrophic cardiomyopathy; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART RATE VARIABILITY; HOLTER MONITORING; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SINUS RHYTHM; STROKE; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONG-TERM CARE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; STROKE; YOUNG ADULT;

EID: 84862486367     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000338156     Document Type: Article

References (23)

1. Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308-1320. (Pubitemid 34250486)
2. Elliott P, McKenna WJ: Hypertrophic cardiomyopathy. Lancet 2004; 363: 1881-1891. (Pubitemid 38748646)
3. Frenneaux MP: Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 2004; 90: 570-575. (Pubitemid 38530183)
4. Christiaans I, van Engelen K, van Langen IM, Birnie E, Bonsel GJ, Elliott PM, Wilde AA: Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. Europace 2010; 12: 313-321.
5. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F: Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000; 102: 858-864.
6. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ: Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003; 42: 873-879. (Pubitemid 37059747)
7. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ: Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 45: 697-704. (Pubitemid 40278968)
8. Lahiri MK, Kannankeril PJ, Goldberger JJ: Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 2008; 51: 1725-1733. (Pubitemid 351608496)
9. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W: Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol 2008; 52: 1353-1365.
10. Kadish AH, Buxton AE, Kennedy HL, Knight BP, Mason JW, Schuger CD, Tracy CM, Winters WL Jr, Boone AW, Elnicki M, Hirshfeld JW Jr, Lorell BH, Rodgers GP, Tracy CM, Weitz HH, American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force, International Society for Holter and Noninvasive Electrocardiology: ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: a report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography) endorsed by the International Society for Holter and Noninvasive Electrocardiology. Circulation 2001; 104: 3169-3178.
11. Lee TH: Ambulatory electrocardiographic and electrophysiological testing; in Libby P, Bonow RO, Mann DL, Zipes DP (eds): Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, ed 8. St. Louis, WB Saunders, 2007, pp 823-830.
12. Kawasaki T, Azuma A, Sakatani T, Hadase M, Kamitani T, Kawasaki S, Kuribayashi T, Sugihara H: Prognostic value of heart rate variability in patients with hypertrophic cardiomyopathy. J Electrocardiol 2003; 36: 333-338. (Pubitemid 37421092)
13. Kawasaki T, Azuma A, Asada S, Hadase M, Kamitani T, Kawasaki S, Kuribayashi T, Sugihara H: Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J 2003; 67: 601-604. (Pubitemid 36834388)
14. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065.
15. Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schömig A: Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999; 353: 1390-1396. (Pubitemid 29192410)
16. Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC, Maron BJ, Leon MB, Epstein SE: Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 1981; 64: 787-796. (Pubitemid 11030133)
17. Takeichi Y, Yokota M, Iwase M, Izawa H, Nishizawa T, Ishiki R, Somura F, Nagata K, Isobe S, Noda A: Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2001; 38: 335-343. (Pubitemid 32721758)
18. Udelson JE, Cannon RO 3rd, Bacharach SL, Rumble TF, Bonow RO: Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia. Comparison to rapid atrial pacing. Circulation 1989; 79: 371-382. (Pubitemid 19055508)
19. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119: e391-e479, erratum in: Circulation 2010; 121:e258.
20. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL: ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442,
21. erratum in: Eur Heart J 2010; 12: 416.
22. Barriales-Villa R, Centurión-Inda R, Fernández- Fernández X, Ortiz MF, Pérez-Alvarez L, Rodríguez García I, Hermida-Prieto M, Monserrat L: Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2010; 63: 985-988.
23. Bahl A, Saikia UN, Talwar KK: Familial conduction system disease associated with hypertrophic cardiomyopathy. Int J Cardiol 2008; 125:e44-e47. (Pubitemid 351418028)